The Most Transformative Drugs of the Past 25 Years: A Survey of Physicians

Kesselheim AS, Avorn J - Nature Reviews Drug Discovery

  • Innovation Incentives and Competition
  • Regulation and Clinical Evidence

Summary:

Approximately 180 expert physicians across 15 medical specialties used an iterative Delphi process to identify the most transformative drugs approved over the past 25 years, with effectiveness and superiority over existing alternatives emerging as the primary factors influencing their assessments. The authors argue that establishing consensus on what constitutes transformative drug innovation can better inform strategic and legislative efforts to catalyze pharmaceutical development.

VIEW SOURCE

Recent Work from PORTAL

Talk bubble graphics representing commentary and opinion.

How Congress Can Fix Expert Advisory Committees

Daval CJR, Kesselheim AS - STAT

  • Regulation and Clinical Evidence
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

International Regulatory Status and Reimbursement Recommendations of Haematological Malignancy Drugs Withdrawn from the FDA Accelerated Approval Pathway

Mulsant SS, Kesselheim AS, Naci H - Journal of Cancer Policy

  • Price, Value, and Access
  • Regulation and Clinical Evidence
Talk bubble graphics representing commentary and opinion.

The Impact of Semantics in Medicines Regulation

Costa E, Kesselheim AS - Journal of Law, Medicine, & Ethics

  • Innovation Incentives and Competition
  • Regulation and Clinical Evidence